Application Nr Approved Date Route Status External Links
BLA125359 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Erwinaze Is Indicated As A Component Of A Multi-Agent Chemotherapeutic Regimen For The Treatment Of Patients With Acute Lymphoblastic Leukemia (All) Who Have Developed Hypersensitivity To E. Coli -Derived Asparaginase. Erwinaze Is An Asparagine Specific Enzyme Indicated As A Component Of A Multi-Agent Chemotherapeutic Regimen For The Treatment Of Patients With Acute Lymphoblastic Leukemia (All) Who Have Developed Hypersensitivity To E. Coli -Derived Asparaginase. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Asparaginase Erwinia Chrysanthemi

Comments